Jerzy Łazarewicz

Dr. Jerzy Łazarewicz


Research Focus & Metrics

Academic Career Length

59Years (1968-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1990 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
JŁJerzy Łazarewicz
Jerzy Łazarewicz
JWJ. T. Wroblewski
J. T. Wroblewski
ECE. Costa
E. Costa

1 December 2000 in Developmental Brain Research
Verified
Journal Article
Closed access
MPMalgorzata Puka-Sundvall
Malgorzata Puka-Sundvall
BGBarbara Gajkowska
Barbara Gajkowska
MCMarcin Cholewinski
Marcin Cholewinski
Klas BlomgrenKlas Blomgren
Klas Blomgren
JŁJerzy Łazarewicz
Jerzy Łazarewicz
HHHenrik Hagberg
Henrik Hagberg

1 September 2003 in Neurochemistry International
Verified
Journal Article
Closed access
EZElzbieta Zieminska
Elzbieta Zieminska
ASAleksandra Stafiej
Aleksandra Stafiej
JŁJerzy Łazarewicz
Jerzy Łazarewicz

1 July 1988 in Neuropharmacology
Verified
Journal Article
Open access
JŁJerzy Łazarewicz
Jerzy Łazarewicz
JWJ.T. Wroblewski
J.T. Wroblewski
MPM.E. Palmer
M.E. Palmer
ECE. Costa
E. Costa
In cultured granule cells prelabeled with [3H]arachidonate the activation of excitatory amino acid receptors by various agonists results in a dose-dependent stimulation of [3H]arachidonic acid release. Glutamate and aspartate were the most potent agonists, whereas N-methyl-D-aspartate, kainate and quisqualate were less potent. Other neurotransmitter receptor agonists--GABA, baclofen and norepinephrine--were inactive, while carbachol induced only a slight effect. Since the transmitter-mediated release of [3H]arachidonate was blocked by phencyclidine, a selective inhibitor of NMDA-sensitive glutamate receptors, it can be inferred that the effects of all other receptor agonists were indirectly mediated via the release of glutamate from granule cells. Aspartate-evoked release was Ca2+-dependent and was abolished by the glutamate receptor inhibitors: Mg2+ ions and 2-amino-5-phosphonovalerate. The inhibitors of phospholipase A2, quinacrine and p-bromophenacyl bromide, decreased the release of [3H]arachidonate in a dose-related manner.

1 December 1978 in Brain Research
Verified
Journal Article
Closed access
MMMaria Dorota Majewska
Maria Dorota Majewska
JSJoanna B. Strosznajder
Joanna B. Strosznajder
JŁJerzy Łazarewicz
Jerzy Łazarewicz

1 October 1985 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
ALAnders Lehmann
Anders Lehmann
JŁJerzy Łazarewicz
Jerzy Łazarewicz
MZMarc Zeise
Marc Zeise